(Q67743320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

main subject

liver transplantation

1 reference

3

B. van Hoek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735524

12 November 2022

author name string

L. Sanchez-Urdazpal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735524

12 November 2022

A. J. Czaja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735524

12 November 2022

R. A. Krom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735524

12 November 2022

R. H. Wiesner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735524

12 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840150208

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840150208

12 November 2022

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

12 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

215-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

Natural history, clinical features, and treatment of autoimmune hepatitis

17 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

The first 100 liver transplantations at the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Liver transplantation (1).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Analysis of HL-A incompatibility in human renal transplants.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Auto-immune chronic active hepatitis: a specific entity? The negative argument

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Mechanisms of Autoimmune Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Immune mechanisms in autoimmune chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Alteration in suppressor cell activity in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150208

7 January 2021

7

56

311

Czaja

1981

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

Annals of clinical research

12 November 2022

8

8

221

Schalm

1976

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

Progress in liver diseases

12 November 2022

26

6

285

Eddleston

1979

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

12 November 2022

40

2

515

Canafax

1983

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150208

12 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735524%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference